Effect of diphenylhydantoin on hypothalamic-pituitary-thyroid function in the rat
- 30 November 1980
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 239 (6) , E468-E473
- https://doi.org/10.1152/ajpendo.1980.239.6.e468
Abstract
Chronic diphenylhydantoin (DPH) administration (5 mg x 100 g body wt-1 x day-1) to the normal rat is associated with a decrease in the serum thyroxine (T4) and triiodothyronine (T3) concentrations without an appropriate rise in the serum thyrotropin (TSH) concentration, suggesting a possible direct effect of DPH on TSH secretion. To further study this possibility, DPH was administered chronically to thyroidectomized, hypothyroid rats. In the hypothyroid rats treated chronically with DPH, serum TSH did not increase, pituitary TSH content was significantly decreased, and the serum TSH response to thyrotropin-releasing hormone (TRH) was decreased compared to that of diluent-treated, hypothyroid rats. Hypothalamic TRH content was similar in DPH and diluent-treated rats. These findings suggest that DPH suppresses pituitary TSH secretion, probably as a thyroid hormone agonist. The effect of a single large dose of DPH (20 mg/100 g body wt) administered to thyroidectomized rats also decreased serum tSH but, in contrast to the findings in chronically treated rats, hypothalamic TRH and pituitary TSH content and the serum TSH responses to TRH were increased. These differences may be due to the acute inhibitory effect of a large dose of DPH on hypothalamic TRH release. Furthermore, because the effect of thyroid hormone on regulating pituitary TSH synthesis and release is dose and time dependent, the effect of DPH as a thyroid hormone agonist on pituitary TSH dynamics may also be variable.This publication has 27 references indexed in Scilit:
- Serum thyroxine, free T4, triiodothyronine, and reverse-T3 in diphenylhydantoin-treated patientsMetabolism, 1979
- FUNCTIONAL CHANGES IN CEREBRAL 5‐HYDROXYTRYPTAMINE METABOLISM IN THE MOUSE INDUCED BY ANTICONVULSANT DRUGSBritish Journal of Pharmacology, 1978
- THYROID HORMONE LEVELS AND PROTEIN BINDING IN PATIENTS ON LONG-TERM DIPHENYLHYDANTOIN TREATMENTClinical Endocrinology, 1977
- Pituitary Thyrotropin (TSH) Rebound Phenomenon and Kinetics of Secretion in the Goitrous Rat: Differential Effects of Thyroxine on Synthesis and Release of TSH1Endocrinology, 1976
- Thyrotropin-Releasing Hormone and Thyroid Hormone Interactions on Thyrotropin Secretion in the Rat: Lack of Inhibiting Effects of Small Doses of Triiodo-L-Thyronine in the Hypothyroid Rat1Endocrinology, 1976
- The Effect of Diphenylhydantoin on Thyroid FunctionJournal of Clinical Endocrinology & Metabolism, 1974
- Thyrotropin-Releasing Hormone in the Hypothalamus of the RatEndocrinology, 1974
- Uptake and Binding of CatecholaminesArchives of Neurology, 1972
- Decreased Serum Free Thyroxine Concentration in Patients Treated with Diphenylhydantoin1Journal of Clinical Endocrinology & Metabolism, 1968
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966